Targeted Therapy for Hepatocellular Carcinoma: What`s New?

Journal Title: Liver Research – Open Journal - Year 2015, Vol 1, Issue 1

Abstract

Hepatocellular carcinoma (HCC), one of the most frequent neoplasms worldwide, causes more than 700,000 deaths per year, and is the third cause of cancer-related mortality.1-3 HCC occurs after years of damage to hepatocytes with inflammatory conditions due to Hepatitis B Virus (HBV) or Hepatitis C Virus (HCV) infection resulting in chronic hepatitis and/ or cirrhosis. The disease incidence is decreasing due to Hepatitis B Virus (HBV) vaccination, whereas rates are steadily increasing in Europe and United States possibly due to increased obesity and Hepatitis C Virus (HCV) infection.3The latest antiviral drug, Sofosbuvir (Sovaldi, Gilead), has achieved notable success in clinical trials and approved against HCV and gives great hopes for treatment and hopefully preventing HCV induced liver cancer. Unfortunately, other risk factors like alcohol abuse, fungal toxins, obesity, and poor diet are also associated with HCC and will not be easily wiped out anytime soon.

Authors and Affiliations

Haluk Yuzugullu

Keywords

Related Articles

Acute Variceal Bleeding in Patients with Liver Cirrhosis with and without Diabetes

Objectives: To study the effect of diabetes mellitus on presentations, course, and outcome of acute variceal bleeding in cirrhotic patients. Methods: We compared 2 matched groups of patients, a diabetic group and non-dia...

Metastatic Liver Disease - Presenting as Multiple Hepatic Cysts

A 59 year-old woman with a history of successfully treated Hepatitis-C, Systemic Lupus Erythematosus, and a remote history of melanoma of the scalp presented to our center for evaluation of abdominal pain, nausea, vomiti...

Hepatitis C Update

The pace of Hepatitis C Virus (HCV) drug development in recent years has accelerated dramatically. But, for patients to benefit from these impressive advances, practitioners (i.e. “us”) need to know the most recent and a...

Iron and Copper Toxicity in Rat Liver: A Kinetic and Holistic Overview

Iron (Fe) and copper (Cu) overloads in rats showed a dose and time dependent metal accumulation in liver with its associated toxicity. The increased contents of the transition metals markedly enhanced the endogenous free...

Hepatic Myelopathy: Case Report and Review of the Literature

Background: Hepatic Myelopathy (HM) is a rare complication of chronic liver disease usually associated with extensive portosystemic shunt of blood, which has been created surgically or has occurred spontaneously, causing...

Download PDF file
  • EP ID EP556413
  • DOI 10.17140/LROJ-1-e001
  • Views 179
  • Downloads 0

How To Cite

Haluk Yuzugullu (2015). Targeted Therapy for Hepatocellular Carcinoma: What`s New?. Liver Research – Open Journal, 1(1), 1-3. https://www.europub.co.uk/articles/-A-556413